Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
Settings
GSK [NYSE]
GlaxoSmithKline plc
Index- P/E14.82 EPS (ttm)3.59 Insider Own- Shs Outstand2.41B Perf Week-0.19%
Market Cap128.05B Forward P/E13.21 EPS next Y4.03 Insider Trans- Shs Float2.42B Perf Month-2.42%
Income8.79B PEG1.79 EPS next Q- Inst Own10.70% Short Float0.40% Perf Quarter-2.63%
Sales44.19B P/S2.90 EPS this Y22.70% Inst Trans0.17% Short Ratio4.04 Perf Half Y-0.71%
Book/sh4.72 P/B11.28 EPS next Y15.64% ROA17.30% Target Price60.33 Perf Year7.75%
Cash/sh2.55 P/C20.87 EPS next 5Y8.30% ROE110.00% 52W Range47.23 - 55.95 Perf YTD2.19%
Dividend2.56 P/FCF51.55 EPS past 5Y4.60% ROI24.90% 52W High-4.88% Beta0.57
Dividend %4.81% Quick Ratio0.80 Sales past 5Y1.70% Gross Margin69.60% 52W Low12.67% ATR0.53
Employees99451 Current Ratio1.10 Sales Q/Q-10.30% Oper. Margin31.70% RSI (14)42.43 Volatility0.86% 0.79%
OptionableYes Debt/Eq2.61 EPS Q/Q-30.90% Profit Margin27.70% Rel Volume0.83 Prev Close53.39
ShortableYes LT Debt/Eq2.32 EarningsFeb 03 Payout52.90% Avg Volume2.40M Price53.22
Recom2.20 SMA20-0.97% SMA50-1.66% SMA2001.31% Volume1,985,725 Change-0.32%
23-Apr-14Upgrade Argus Hold → Buy
28-May-13Upgrade Deutsche Bank Hold → Buy
11-Jan-11Upgrade Jefferies Hold → Buy
02-Jun-10Upgrade Jefferies Hold → Buy
16-Feb-10Upgrade JP Morgan Underweight → Neutral $26
13-Jan-10Downgrade Credit Suisse Outperform → Underperform
24-Nov-09Initiated Leerink Swann Mkt Perform
16-Nov-09Initiated Deutsche Securities Hold
12-Nov-09Initiated Barclays Capital Equal Weight
23-Oct-09Downgrade Jefferies & Co Buy → Hold
17-Mar-09Initiated Credit Suisse Outperform
26-Jan-09Initiated Jefferies & Co Buy
14-Nov-08Downgrade UBS Buy → Neutral
18-Apr-08Downgrade JP Morgan Neutral → Underweight
11-Feb-08Upgrade UBS Neutral → Buy
01-Feb-08Upgrade HSBC Securities Underweight → Neutral
24-Oct-07Initiated Bernstein Mkt Perform
06-Sep-07Initiated UBS Neutral
25-Jul-07Downgrade Bear Stearns Peer Perform → Underperform
25-May-07Reiterated Banc of America Sec Neutral $62 → $57
22-Jul-14 11:30AM  What To Buy: Top 3 Buy-Rated Dividend Stocks: STWD, ESV, GSK at TheStreet
09:32AM  Here's What You Need to Know About AbbVie and GlaxoSmithKline's Upcoming Earnings at Motley Fool
21-Jul-14 10:40AM  Eyes Down For GlaxoSmithKline plc Results at Motley Fool
09:53AM  3 Household-Name Stocks With Dividend Yields Over 3% And P/E Ratios Under 15 at Seeking Alpha
09:53AM  5 More Possible Partners For MannKind's Afrezza, Each With A Strong Diabetes Care Franchise at Seeking Alpha
18-Jul-14 09:15AM  [video] Europes Week Ahead: BOE in Rate-Rise Debate at MarketWatch
17-Jul-14 10:18AM  3 Things That Say GlaxoSmithKline plc Is A Buy at Motley Fool
08:46AM  Today's Top Health Care Stocks to Watch: AbbVie, GlaxoSmithKline, and Shire at Motley Fool
05:09AM  Is GlaxoSmithKline plc The World's Most Undervalued Company? at Motley Fool
04:58AM  GSK confirms it fired staff for corruption in China in 2001 Reuters
04:08AM  Glaxo Fired Employees in 2001 After China Bribery Probe at Bloomberg
16-Jul-14 05:42PM  Theravance/Glaxo Commence Global Late stage Study on COPD Zacks
10:39AM  The Risks Of Investing In GlaxoSmithKline Plc at Motley Fool
02:24AM  GSK and Theravance Announce Initiation of Phase III Programme With Fixed Dose Triple Combination Treatment FF/UMEC/VI in Patients With COPD Marketwired
15-Jul-14 05:36PM  Time to Fall Back in Love With Exelixis Inc.? at Motley Fool
14-Jul-14 11:40AM  China indicts U.S., British corporate investigators at USA TODAY
11:32AM  China Reveals Charges in Glaxo Case for a British-American Couple at New York Times
11:32AM  China Reveals Charges for British-American Couple in Case Involving Glaxo at New York Times
11:05AM  After Another Shire PLC Bid, Could AstraZeneca plc Or GlaxoSmithKline plc Be Next? at Motley Fool
10:24AM  How Will GlaxoSmithKline (GSK) Stock Be Impacted By China Investigation? at TheStreet
13-Jul-14 11:39PM  China indicts U.S., British corporate investigators at USA TODAY
11-Jul-14 02:00PM  A Global Pharma Boom Is Coming... Here's How To Profit StreetAuthority Network
06:52AM  [video] Big pharma's big battle with Alzheimer's at CNBC
10-Jul-14 02:18PM  Better Buy: GlaxoSmithKline vs. AstraZeneca at Motley Fool
02:12PM  Evaluating GlaxoSmithKline's Dividend at Seeking Alpha
02:10AM  Summer Selection: Tobacco, Pharma Or Retail Stocks? at Motley Fool
09-Jul-14 06:27AM  2 Dividend Champions Trading At Rock-Bottom Levels: HSBC Holdings plc And GlaxoSmithKline plc at Motley Fool
08-Jul-14 05:27PM  GlaxoSmithKline Is Moving Forward After Woeful Performance at Seeking Alpha
11:00AM  Novartis' CTL109 Gets Breakthrough Therapy Designation from the FDA Zacks
09:26AM  Here's Why Pfizer Should Buy GlaxoSmithKline at Motley Fool
06:39AM  China aims to handle GSK trial 'according to law,' Reuters says at theflyonthewall.com
07-Jul-14 03:45PM  Glaxo's Two Cancer Drugs Get EU Nod Zacks
11:00AM  Glaxo/Theravance Drug Gets Japanese Approval Zacks
09:35AM  Is Hikma Pharmaceuticals Plc A Better Buy Than GlaxoSmithKline plc Or Shire PLC? at Motley Fool
09:04AM  Mondays Top Biotech Stories: Spectrum, Bristol-Myers Squibb, GSK, and Theravance at Motley Fool
08:06AM  Glaxo, Theravance announce Japanese approval for Anoro Ellipta at theflyonthewall.com
08:00AM  Anoro(R) Ellipta(R) (Umeclidinium/Vilanterol) Gains Approval in Japan for the Treatment of COPD Marketwired
04:50AM  Why The Chinese Corruption Saga Makes GlaxoSmithKline plc A Dicey Pick at Motley Fool
06-Jul-14 08:34PM  A Big Pharma Sex Tape Compounds China Woes at Motley Fool
08:03AM  Should You Take a Chance With GlaxoSmithKline? at Wall St. Cheat Sheet
03-Jul-14 12:04PM  Ligand Pharmaceuticals: Appendix at Seeking Alpha
09:48AM  Should You Invest In Shire PLC Instead Of GlaxoSmithKline plc And AstraZeneca plc? at Motley Fool
05:33AM  Will The Sex Tape Be As Bad As It Gets For GlaxoSmithKline plc? at Motley Fool
02-Jul-14 12:36PM  Why Thousands Of Men Like JPMorgan CEO Jamie Dimon Are Getting Throat Cancer at Forbes
12:36PM  Why Thousands Of Men Like J.P. Morgan CEO Jamie Dimon Are Getting Throat Cancer at Forbes
06:48AM  Is AstraZeneca plcs Latest Director Deal A Game-Changer? at Motley Fool
01-Jul-14 01:02PM  Why GoPro, GW Pharmaceuticals, and Amicus Therapeutics Are Today's 3 Best Stocks at Motley Fool
11:35AM  Confusing Messages For Investors And Multinationals From China's Healthcare Reforms at Forbes
11:35AM  Confusing Messages For Investors and Multinationals From China's Healthcare Reforms at Forbes
10:52AM  This COPD Investment Opportunity Isn't What it Seems at Motley Fool
10:50AM  Glaxo/Theravance Seek to Expand Breo Ellipta's Label Zacks
06:15AM  2 Breakthrough Vaccines Command Investor Focus at Motley Fool
30-Jun-14 07:36PM  Dear Facebook, Please Experiment On Me at Forbes
04:20PM  Glaxo's Label Expansion Plans Marred as Arzerra Disappoints Zacks
11:51AM  European shares close lower but book monthly gain at CNBC
11:51AM  European shares close flat, easyJet weighs at CNBC
11:18AM  European shares lower; Euro zone inflation steady at CNBC
10:05AM  European shares lower; Euro zone inflation steady at CNBC
09:17AM  Here's Everything We Know About The GlaxoSmithKline Sex Tape And The Chinese Bribery Allegations Business Insider
08:04AM  GSK and Theravance Announce Submission to US Regulatory Authorities for Fluticasone Furoate/Vilanterol in Asthma Marketwired
07:28AM  European shares lower; Euro zone inflation steady at CNBC
06:10AM  European shares flat; Euro zone inflation steady at CNBC
06:08AM  European shares flat; Euro zone inflation steady at CNBC
05:45AM  How GlaxoSmithKline plc's Dividends Could Power Up Your Portfolio at Motley Fool
05:08AM  Europe drifts higher, euro zone inflation steady at CNBC
03:39AM  Europe drifts higher, euro zone inflation data due at CNBC
03:17AM  Europe drifts higher, euro zone inflation data due at CNBC
01:30AM  [video] Sex tape adds fire to GSK China scandal at CNBC
12:37AM  [$$] Sex Video of GlaxoSmithKline China Executive Led to Hiring of Private Sleuths at The Wall Street Journal
29-Jun-14 03:37PM  Sex Video of GlaxoSmithKline China Executive Led to Hiring of Private Sleuths The Wall Street Journal
28-Jun-14 05:00PM  Is GlaxoSmithKline's Dividend Safe? at Motley Fool
26-Jun-14 01:30PM  Glaxo's Promacta in Phase III for MDS Zacks
01:30PM  Glaxo's Promacta in Phase III for MDS
25-Jun-14 05:10PM  Isis Pharma Gets $1M Milestone Payment from Glaxo Zacks
05:10PM  Isis Pharma Gets $1M Milestone Payment from Glaxo
04:05AM  How Strong Are GlaxoSmithKline plc's Dividends? at Motley Fool
04:05AM  How Strong Are GlaxoSmithKline plc's Dividends?
24-Jun-14 08:14AM  GlaxoSmithKline plc Can Still Make You Rich at Motley Fool
08:14AM  GlaxoSmithKline plc Can Still Make You Rich
07:37AM  Bank Analysts Say Pfizer-AstraZeneca Merger Still Makes Sense at New York Times
07:37AM  Bank Analysts Say Pfizer-AstraZeneca Merger Still Makes Sense
07:02AM  Isis Pharmaceuticals receives $1M milestone payment from GlaxoSmithKline at theflyonthewall.com
07:02AM  Isis Pharmaceuticals receives $1M milestone payment from GlaxoSmithKline
03:57AM  Will GlaxoSmithKline plc Become A Bid Target? at Motley Fool
03:57AM  Will GlaxoSmithKline plc Become A Bid Target?
23-Jun-14 04:45PM  Cepheid Forms Pharma Alliance to Fight Antibiotic Resistance Zacks
04:45PM  Cepheid Forms Pharma Alliance to Fight Antibiotic Resistance
08:48AM  Glaxo Dumps Firm for Praying on College Grads for Clinical Trials
21-Jun-14 03:02PM  Can GlaxoSmithKline Overcome This Huge Incoming Loss?
20-Jun-14 09:34AM  Beginners' Portfolio: The Investor's Dilemma at Motley Fool
09:34AM  Beginners' Portfolio: The Investor's Dilemma
03:34AM  3 Stocks To Benefit From Low Inflation at Motley Fool
03:34AM  3 Stocks To Benefit From Low Inflation
19-Jun-14 04:00PM  Vertex Pharmaceuticals-Johnson & Johnson Collaborate on Flu Drug Zacks
10:27AM  ISIS Pharma Trades Up Premarket; NYT Says Has Potential Heart Attack Drug Benzinga
06:50AM  Why GlaxoSmithKline plc Really Yields 7% at Motley Fool
06:50AM  Why GlaxoSmithKline plc Really Yields 7%
17-Jun-14 11:52AM  China-UK visit: Are the great expectations justified? at CNBC
11:52AM  China-UK visit: Are the great expectations justified?
11:19AM  China-UK visit: Are the great expectations justified? at CNBC
GlaxoSmithKline plc creates, discovers, develops, manufactures, and markets pharmaceutical products, such as vaccines, over-the-counter medicines, and health-related consumer products worldwide. The company provides pharmaceutical products in various therapeutic areas, such as respiratory, anti-virals, central nervous system, cardiovascular and urogenital, metabolic, antibacterials, oncology and emesis, dermatology, rare diseases, immuno-inflammation, vaccines, and HIV. It also offers consumer health products in total wellness, oral care, nutritional, and skin health areas. The company's total wellness products comprise Panadol for the treatment of headache and joint pain, fever, and cold symptoms; NicoDerm, NiQuitin CQ, and Nicabate for the treatment of nicotine withdrawal as an aid to quitting smoking; and ENO Tums, a rapid relief antacid. Its oral care products include Sensodyne for the prevention of dental sensitivity; Polident, Poligrip, and Corega to enhance comfort of fitted dentures and to clean dentures; Aquafresh for the prevention of caries, gum disease, and bad breath; and Parodontax to help stop bleeding gums and gum health. The company's nutrition products comprise Horlicks and Maxinutrition for nutrition; and skin health products include Physiogel, a face and body care product for dry, sensitive, and irritated skin, and Oilatum, a soothing treatment for eczema and dry skin conditions. In addition, it provides prescription medicines; and paediatric and adult vaccines against various infectious diseases. The company has a strategic cancer immunotherapy collaboration with Adaptimmune Limited to develop and commercialize NY-ESO-1 clinical cancer program. GlaxoSmithKline plc was founded in 1935 and is headquartered in Brentford, the United Kingdom.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
GLAXOSMITHKLINE PLC10% OwnerMay 09Buy8544835.30317,7702,715,292,313,28130,576,072May 13 04:43 PM
GLAXOSMITHKLINE PLC10% OwnerApr 01Buy12.00103,7621,245,1441,989,598Apr 02 12:42 PM
GLAXOSMITHKLINE PLCFormer 10% OwnerFeb 19Buy14.0035,000490,0001,356,533Feb 20 06:56 PM
GLAXOSMITHKLINE PLC10% OwnerFeb 11Buy12850698.95342,2294,397,881,850,96030,258,302Feb 13 04:41 PM
GLAXOSMITHKLINE PLCFormer 10% ShareholderFeb 10Buy12.00143,7731,725,276143,773Feb 12 05:56 PM
GLAXOSMITHKLINE PLC10% OwnerOct 29Buy4913613.18130,473641,093,852,43429,916,073Oct 29 05:37 PM
GLAXOSMITHKLINE PLC10% OwnerJul 30Buy111850855.503,064,407342,756,544,550,18929,785,600Aug 01 09:23 AM